StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
IRLAIRulya Therapeutics Inc.
stockpulse.co.kr
Nasdaq
$33.08▼ 1.72%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 3d agoAfter-hours26.10.22 06:15
    144Ownership#●●●#●●●

    IRulya Therapeutics Inc.

    Thye Dirk, an insider at IRulya Therapeutics Inc., has filed a Form 144 to report a proposed sale of company securities. This filing serves as a formal notification of the insider's plan to dispose of their holdings.…more

    $33.08-1.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 5d agoAfter-hours26.10.20 05:16
    3Ownership

    IRulya Therapeutics Inc.

    Catherine M. Bonuccelli, an officer or major shareholder of IRulya Therapeutics Inc., has executed a power of attorney for the filing of SEC Forms 3, 4, and 5. This document appoints Brigette Roberts and John Militello as attorneys-in-fact to fulfill reporting obligations under Section 16(a) of the Securities Exchange Act.…more

    $33.08-1.72%vs prev close
    View filingShare
  • 5d agoAfter-hours26.10.20 05:15
    3Ownership

    IRulya Therapeutics Inc.

    James Elwood Valentine of IRulya Therapeutics Inc. has executed a power of attorney authorizing designated company representatives to file Forms 3, 4, and 5 with the SEC. This action facilitates compliance with reporting requirements under Section 16(a) of the Securities Exchange Act for officers, directors, or beneficial owners.…more

    $33.08-1.72%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.